337 related articles for article (PubMed ID: 15177489)
1. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ;
Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
[TBL] [Abstract][Full Text] [Related]
2. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
Vacheva-Dobrevski R; Kovachev S; Nacheva A; Stoev S; Vasilev N
Akush Ginekol (Sofiia); 2004; 43(1):20-3. PubMed ID: 15168649
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.
Studena V; Sycova Z; Helpianska L; Sorkovska D; Pichna P; Lacka J; Hlavacova E; Oravcova E; Krcmery V; Studena M
J Chemother; 1995 Nov; 7 Suppl 4():204-5. PubMed ID: 8904157
[No Abstract] [Full Text] [Related]
5. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
6. Itraconazole and fluconazole in oropharyngeal candidiasis.
van der Bijl P; Arendorf TM
Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
[TBL] [Abstract][Full Text] [Related]
7. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Di Lorenzo G
Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
9. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
Mondal RK; Singhi SC; Chakrabarti A; M J
Pediatr Crit Care Med; 2004 Nov; 5(6):561-5. PubMed ID: 15530193
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Barbarini G; Di Lorenzo G
Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
[TBL] [Abstract][Full Text] [Related]
12. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter study of fluconazole in the treatment of oropharyngeal candidiasis in immunodepressed patients].
Muñoz P; Moreno S; Garau X; López Bernaldo de Quirós JC; Berenguer J; More J; Bouza E
Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):560-4. PubMed ID: 2099857
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
Jandourek A; Vaishampayan JK; Vazquez JA
AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
De Wit S; O'Doherty E; De Vroey C; Clumeck N
J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
[TBL] [Abstract][Full Text] [Related]
17. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis.
Woolley PD; Higgins SP
Br J Clin Pract; 1995; 49(2):65-6. PubMed ID: 7779645
[TBL] [Abstract][Full Text] [Related]
19. Candidiasis at ICAAC.
Barr D; Smart T
GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
[TBL] [Abstract][Full Text] [Related]
20. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
